联合王国拨款900万英镑,用于加强镰状细胞治疗,扩大先进技术的普及。 UK allocates £9M to enhance sickle cell treatment, expanding advanced technology access.

联合王国政府已拨款900万英镑,用于改善英格兰的镰状细胞治疗,重点是扩大使用先进的Spectra Optia技术,该技术进行自动细胞交换。 The UK government has allocated £9 million to improve sickle cell treatment in England, focusing on expanding access to advanced Spectra Optia technology, which performs automated cell exchanges. 这项投资旨在使治疗更容易获得,并减少住院人数,有可能每年节省1 290万英镑的国民保健服务。 This investment aims to make treatment more accessible and reduce hospital stays, potentially saving the NHS £12.9 million annually. 英格兰在镰状细胞基因编辑治疗方面也处于领先地位,为影响约17 000人的这一疾病提供功能性治疗。 England is also leading in gene-editing therapy for sickle cell, offering a functional cure for the disease affecting about 17,000 people.